Home › Stocks › APGE › All Fund Holders
APGE — APOGEE THERAPEUTICS INC · All Fund Holders
Funds holding (latest): 43 · Reported value held: $3.29B
| Fund | Quarter | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|---|
| BlackRock Inc history | Q2 2026 | 5.51M | $730.95M | 0.01% | Add |
| Fidelity Management & Research (FMR) history | Q2 2026 | 2.49M | $330.91M | 0.02% | Reduce |
| Balyasny Asset Management history | Q2 2026 | 2.17M | $287.37M | 0.38% | Add |
| Goldman Sachs Group history | Q2 2026 | 1.69M | $224.76M | 0.02% | Add |
| Vanguard Group history | Q4 2025 | 2.86M | $215.71M | 0.00% | Add |
| Millennium Management history | Q2 2026 | 1.50M | $199.29M | 0.08% | Add |
| Janus Henderson Group history | Q1 2026 | 2.36M | $198.81M | 0.10% | Add |
| Morgan Stanley history | Q2 2026 | 1.42M | $188.70M | 0.01% | Add |
| Geode Capital Management history | Q2 2026 | 1.31M | $174.56M | 0.01% | Add |
| Bank of America Corp history | Q2 2026 | 1.13M | $149.47M | 0.01% | Add |
| Soros Fund Management history | Q2 2026 | 564.50K | $74.93M | 1.05% | New |
| Wellington Management Group history | Q2 2026 | 564.33K | $74.90M | 0.01% | Reduce |
| Northern Trust Corp history | Q2 2026 | 445.15K | $59.09M | 0.01% | Add |
| Charles Schwab Investment Management history | Q2 2026 | 443.66K | $58.89M | 0.01% | Add |
| Franklin Resources history | Q2 2026 | 363.38K | $48.23M | 0.01% | Reduce |
| Citigroup Inc history | Q2 2026 | 289.46K | $38.42M | 0.01% | Add |
| D. E. Shaw & Co history | Q2 2026 | 246.09K | $32.66M | 0.02% | Add |
| Capital World Investors history | Q1 2026 | 348.67K | $29.35M | 0.00% | Add |
| UBS Group AG history | Q2 2026 | 201.83K | $26.79M | 0.00% | Reduce |
| BNY Mellon history | Q2 2026 | 152.81K | $20.28M | 0.00% | Add |
| Farallon Capital Management history | Q1 2024 | 305.00K | $20.27M | 0.09% | New |
| Renaissance Technologies history | Q2 2026 | 146.80K | $19.48M | 0.03% | New |
| Deutsche Bank AG history | Q2 2026 | 98.98K | $13.14M | 0.00% | Add |
| Two Sigma Investments history | Q2 2026 | 94.76K | $12.58M | 0.01% | Reduce |
| Marshall Wace history | Q2 2026 | 77.47K | $10.28M | 0.01% | Reduce |
| Prudential Financial history | Q2 2026 | 76.62K | $10.17M | 0.01% | Add |
| Citadel Advisors history | Q2 2026 | 58.86K | $7.81M | 0.00% | Reduce |
| Point72 Asset Management history | Q2 2026 | 54.56K | $7.24M | 0.01% | Add |
| Wells Fargo & Co history | Q2 2026 | 45.85K | $6.09M | 0.00% | Add |
| Invesco Ltd history | Q2 2026 | 39.32K | $5.22M | 0.00% | Add |
| Manulife Financial history | Q2 2026 | 33.56K | $4.45M | 0.00% | Reduce |
| Legal & General Investment Management America history | Q2 2026 | 32.70K | $4.34M | 0.00% | Add |
| Moore Capital Management history | Q2 2026 | 20.00K | $2.65M | 0.04% | New |
| JPMorgan Chase & Co history | Q2 2026 | 14.90K | $1.98M | 0.00% | New |
| Baron Funds history | Q1 2026 | 15.00K | $1.26M | 0.00% | New |
| AQR Capital Management history | Q2 2026 | 7.96K | $1.06M | 0.00% | Reduce |
| Norges Bank Investment Management history | Q2 2024 | 12.12K | $476.96K | 0.00% | Add |
| Principal Global Investors history | Q2 2026 | 3.45K | $457.65K | 0.00% | Add |
| Davidson Kempner Capital Management history | Q3 2023 | 10.00K | $212.70K | 0.00% | New |
| PNC Financial Services history | Q2 2026 | 526 | $69.82K | 0.00% | Add |
| T. Rowe Price Associates history | Q2 2026 | 237.21K | $31.49K | 0.00% | Reduce |
| Fidelity International (FIL) history | Q2 2026 | 105 | $13.94K | 0.00% | Hold |
| Amundi US history | Q1 2025 | 35 | $1.23K | 0.00% | Add |